JFG
ASND icon

Jefferies Financial Group’s Ascendis Pharma A/S ASND Stock Holding History

Jefferies Financial Group’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50,000
Closed -$8.63M – 1449
2025
Q2 		$8.63M Buy
+50,000
New +$8.14M 0.07% 201

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jefferies Financial Group's ASND Position: Q2 2024 in Review

Jefferies Financial Group sold out of Ascendis Pharma A/S (ASND) in Q2 2024, closing a stake of 24,151 shares — an estimated $3.65M sold.

Jefferies Financial Group first reported a position in ASND in Q3 2023 and held it in 3 quarters. The position peaked at $3.65M in Q1 2024. 203 funds tracked by Wall St. Rank hold ASND as of Q2 2024.

  • Jefferies Financial Group reported no remaining Ascendis Pharma A/S position as of Q2 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 24,151 Ascendis Pharma A/S shares in Q2 2024, an estimated $3.65M.
  • Jefferies Financial Group first reported a position in Ascendis Pharma A/S in Q3 2023 and held it in 3 quarters.
  • Jefferies Financial Group's Ascendis Pharma A/S position peaked at $3.65M in Q1 2024.
  • 203 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2024.

Based on Jefferies Financial Group's 13F filing for Q2 2024, filed 13 Aug 2024.